NEW YORK (GenomeWeb) – Cancer Genetics today said that it has received CLIA and New York State approvals to offer its mature B-cell neoplasm array for follicular lymphoma (MatBA-FL) and mantle-cell lymphoma (MatBA-MCL) as laboratory-developed tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.